EUVIMEDDescobrir EUVIMED
Randomisierte kontrollierte StudieStudienprotokollOpen access

Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial

Ze Liu iD, Jialiang Yao iD, Xinyi Lu iD, Yun Yang iD, Bin Luo iD, Yanhong Wang iD, Xi Cheng iD, Wei Jiang iD, Guowang Yang iD, Jing Xiao iD, Jiuda Zhao iD, Jianhui Tian iD

JMIR Research Protocols · 2026-06-12 · 15 · e88625-e88625

DOI: 10.2196/88625 ↗

At a glance

Randomisierte kontrollierte Studie in JMIR Research Protocols, published online on 2026-06-12. Written by Ze Liu and 11 co-authors. Institution: Clinical Cancer Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, No. 274, Zh…. Major MEDLINE topics: Ovarian Neoplasms, Drugs, Chinese Herbal. 44 references. The full text is freely available in PubMed Central.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Background

Psychoneurological symptom clusters (PNSCs) are common in patients with ovarian cancer and are associated with reduced quality of life, treatment interruption, and poor prognosis. However, effective interventions for PNSCs remain limited. Traditional Chinese medicine may provide comprehensive benefits for symptom management.

Objective

This study aims to evaluate the efficacy and safety of the TiaoShenZhiAi (TSZA) regimen in alleviating PNSCs in patients with ovarian cancer and to assess its effects on quality of life and survival outcomes.

Methods

A total of 316 patients with ovarian cancer aged 18 to 70 years with PNSCs will be included and randomly divided into 2 parallel groups. Both groups will receive standard treatment for ovarian cancer as the basic treatment. The intervention group will receive the TSZA regimen, that is, Compound Ciwujia Granules (containing Acanthopanax senticosus and Schisandra chinensis ) combined with psychological intervention. The control group will receive a low-dose active control (simulated Compound Ciwujia Granules) combined with psychological intervention. The primary outcome is the remission rate of PNSCs at 3 months. The secondary outcome measures include the Pittsburgh Sleep Quality Index, the Patient Health Questionnaire-9, the Generalized Anxiety Disorder-7 scale, the revised Piper Fatigue Scale, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Quality of Life Scale, the traditional Chinese medicine syndrome scale, sleep quality, sleep diary, and the 1-year survival analysis. In addition, this study also includes a series of exploratory indicators (including functional magnetic resonance imaging, biomarkers of peripheral blood and tumor tissue, proportion of immune cells, cytokine levels, hypothalamic-pituitary-adrenal axis function, and immune gene expression analysis) and safety indicators (including vital signs, liver and kidney function, and electrocardiogram). The study outcomes will be evaluated based on different indicators during the treatment period (baseline and the 1st, 2nd, and 3rd mo of enrollment) and the follow-up period (the 6th, 9th, and 12th mo of enrollment). Data analysis will be conducted using R (version 4.5.3) software. A one-sided P value of

Subjects

MeSH terms (MEDLINE)

Ovarian NeoplasmsDrugs, Chinese HerbalHumansFemaleDouble-Blind MethodQuality of LifeRandomized Controlled Trials as TopicMulticenter Studies as TopicAdultMiddle AgedAdolescentAgedMedicine, Chinese TraditionalYoung Adult

Author keywords

TSZA regimenTiaoShenZhiAiclinical trial protocolovarian cancerpsychoneurological symptom clusterrandomized controlled trialtraditional Chinese medicine

Substances

Drugs, Chinese Herbal

Authors and institutions

  • Clinical Cancer Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, No. 274, Zhijiang Middle Road, Jing'an District, Shanghai, 200071, China, +86 137…
  • Oncology Institute of Traditional Chinese Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, China.
  • Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China.
  • Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, Shanghai, China.
  • Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Beijing, Beijing, China.
  • Department of Gynecology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China.

ORCID profiles: Ze Liu, Jialiang Yao, Xinyi Lu, Yun Yang, Bin Luo, Yanhong Wang, Xi Cheng, Wei Jiang, Guowang Yang, Jing Xiao, Jiuda Zhao, Jianhui Tian

Cite

APA

Liu, Z., Yao, J., Lu, X., Yang, Y., Luo, B., Wang, Y., Cheng, X., Jiang, W., Yang, G., Xiao, J., Zhao, J., & Tian, J. (2026). Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial. JMIR Research Protocols, 15, e88625-e88625. https://doi.org/10.2196/88625

Vancouver

Liu Z, Yao J, Lu X, Yang Y, Luo B, Wang Y, et al. Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial. JMIR Research Protocols. 2026;15:e88625-e88625. doi:10.2196/88625

BibTeX
@article{Liu2026,
  author = {Liu, Ze and Yao, Jialiang and Lu, Xinyi and Yang, Yun and Luo, Bin and Wang, Yanhong and Cheng, Xi and Jiang, Wei and Yang, Guowang and Xiao, Jing and Zhao, Jiuda and Tian, Jianhui},
  title = {Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e88625--e88625},
  doi = {10.2196/88625}
}
Start for free →